Tetra Pak Launches Bioreactor RF: Lowering Costs, Scaling Fermentation-Derived Ingredients

London, United Kingdom — 08 July 2026

Tetra Pak has launched its Bioreactor RF, marking its entry into industrial-scale fermentation hardware following the acquisition of Bioreactors.net in December 2025. This system directly addresses the industry's need for scalable, reliable production of fermentation-derived ingredients and novel food products, moving beyond pilot-scale development. The Bioreactor RF accommodates fermentation processes utilising yeast, bacteria, and fungi to convert raw materials into various food components.

The unit's core design focuses on cost efficiency and risk mitigation. Tetra Pak asserts that the system can cut operational costs by as much as 12% through enhanced process stability, minimised contamination risks, and simplified daily operations. Investment costs are also projected to decrease by up to 8%, attributing this to the bioreactor's preassembled, factory-tested nature and integrated platform design that negates separate support structures.

A key innovation is the patented magnetic agitation technology, which eliminates mechanical seals—a frequent source of contamination and process instability in conventional designs. This magnetic system is engineered to maintain consistent power and oxygen transfer across its full size range (10 to 50,000 litres), overcoming common scale-up challenges. Rafael Barros, Director of Tetra Pak's new food business stream, emphasised that the Bioreactor RF is built to ensure repeatable performance, mitigate operational risk, and simplify complexity for operators.

The Bioreactor RF also incorporates self-adjusting control functions, predefined operating strategies, and integrated data monitoring. Features such as self-tuning control loops, integrated mass balance, OPC UA connectivity, and event logging provide operators with advanced tools for process analysis and data extraction, aiming to reduce batch loss and improve consistency.

What this means for United Kingdom

UK supplement manufacturers reliant on or exploring fermentation-derived ingredients will find enhanced avenues for cost-efficient scale-up. The potential for a 12% reduction in operating costs and 8% in capital expenditure directly addresses margin pressures in high-cap-ex sectors. Brand owners can leverage increased ingredient availability and stability to diversify product lines with novel fermented components, potentially differentiating in a crowded market. Procurement teams should evaluate existing and planned fermentation projects against this new benchmark for ROI and long-term supply chain resilience, especially for alternative protein or precision fermentation-derived compounds. Early adopters could gain a first-mover advantage in commercialising next-generation ingredients, pending FSA approval for novel food applications. This technology also sets a new standard for operational reliability, which is crucial for meeting stringent UK food safety and quality regulations.

Built for various production scales, the Bioreactor RF offers operational uniformity with a consistent design platform, control logic, and operating philosophy across all sizes. This standardisation facilitates operator training and streamlines multi-site production management. Its modular configuration allows for flexible adaptation of alarm thresholds, impellers, and other settings to evolving process requirements, further supported by optional features such as accessible impellers and a dual exhaust system for continuous processing.

Many leading brands in this category are manufactured in partnership with Supplement Factory.